Aesthetic practitioners were invited to the UK launch of Injectable Collagen at the Royal Society of Medicine on July 26.
Hosted by aesthetic supplier Vida Aesthetics, the event included a presentation and a live demonstration from Italian aesthetic practitioner Dr Giovanni Merone.
Dr Merone explained that the class III medical device is a heterologous type I collagen powder, which when mixed with Water for Injection and administered through intradermal infiltration, aims to restore existing collagen and stimulate the production of new collagen to promote natural regeneration. He said that the product should be used in two to four treatments, depending on the patient’s skin condition, and results of increased skin density and elasticity are visible after seven to 14 days.
Dr Merone also outlined how Injectable Collagen has been successful in wound healing and scar treatment, and detailed how the product can be used in combination with other treatments such as CO2 laser, thread lifting, fillers and botulinum toxin. According to clinical research presented, there have been no complications or adverse reactions to Injectable Collagen and no histological damage is evident.
Attendee Dr Mohammed Ahmad, who has been using Injectable Collagen in his clinic at 10 Harley Street, said, “I feel that Injectable Collagen fills a gap for patients who don’t want anything too invasive as it offers a softer approach and more subtle rejuvenation. I’ve started using it with successful results and have been very satisfied. The studies that have been presented today have been interesting, however I believe the best evidence you have is the research you do yourself, and is gathered through patient feedback.”
Eddy Emilio, director of Vida Aesthetics, said of the evening, “It went extremely well. People were very engaged and asked lots of questions, which was great. Injectable Collagen is the first of its kind and is very unique – there’s nothing else like it at the moment. We believe it will take the market by a storm.”